Stephens Investment Management Group’s BioTelemetry, Inc. BEAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-364,459
Closed -$26.3M 189
2020
Q4
$26.3M Sell
364,459
-684,399
-65% -$35.8M 0.39% 103
2020
Q3
$47.8M Buy
1,048,858
+143,844
+16% +$6.01M 0.85% 54
2020
Q2
$40.9M Sell
905,014
-19,537
-2% -$875K 0.74% 62
2020
Q1
$35.6M Buy
924,551
+71,681
+8% +$3.3M 0.86% 55
2019
Q4
$39.5M Buy
852,870
+34,440
+4% +$1.49M 0.74% 62
2019
Q3
$33.3M Buy
818,430
+149,900
+22% +$6.47M 0.67% 69
2019
Q2
$32.2M Buy
668,530
+199,171
+42% +$10.5M 0.61% 75
2019
Q1
$29.4M Sell
469,359
-1,873
-0.4% -$129K 0.6% 79
2018
Q4
$28.1M Buy
471,232
+24,135
+5% +$1.45M 0.67% 74
2018
Q3
$28.8M Buy
+447,097
New +$24.9M 0.53% 84

Other funds holding BEAT

Stephens Investment Management Group's BEAT Position: Q1 2021 in Review

Stephens Investment Management Group sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 364,459 shares — an estimated $26.3M sold.

Stephens Investment Management Group first reported a position in BEAT in Q3 2018 and held it in 10 quarters. The position peaked at $47.8M in Q3 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

  • Stephens Investment Management Group reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
  • Stephens Investment Management Group sold 364,459 BioTelemetry, Inc. shares in Q1 2021, an estimated $26.3M.
  • Stephens Investment Management Group first reported a position in BioTelemetry, Inc. in Q3 2018 and held it in 10 quarters.
  • Stephens Investment Management Group's BioTelemetry, Inc. position peaked at $47.8M in Q3 2020.
  • 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Stephens Investment Management Group's 13F filing for Q1 2021, filed 14 May 2021.